Abstract:Objective Atherosclerosis is widely accepted as a chronic inflammatory disease. Serum biomarkers for vulnerable plaques not only serve as diagnostic tools for the identification of patients with acute coro-nary syndrome, but also assist the identification of high-risk patients. However, the existing data are limited and conflicting. In the present study, we determined whether the plasma levels of interleukin-1β (IL-1β) are correlated with adverse cardiac outcomes in patients with ST-evaluate acute myocardial infarction (STEAMI) undergoing pri-mary percutaneous coronary intervention (PCI). Effect of the plasma intedeukin-1β level on prognosis of patients with ST-segment elevation acute myocardial infarction. Method This prospective single-center study included 96 patients with SIEAMI with onset < 12 h who underwent primary PCI, 271 patients with stable angina pectoris (SAP) and 148 control subjects without coronary artery disease who were consecutively admitted to hospital be-tween Mar, 2006 and Mar, 2008. Plasma IL-1β levels were measured by enzyme-linked immunosorbent assay in all subjects. The patients with STEAMI were then followed prospectively for the occurrence of major adverse car-diac events (MACE) (including cardiovascular death, non-fatal myocardial infarction, heart failure, and cardio-genie shock) during hospitalization. We determined the association between IL-1β levels with the risk of MACE using multivariate logistic regression. Results Compared with the SAP patients and control subjects, patients with STEAMI had higher levels of IL-1β (P < 0.05). During hospitalization, 32 patients (33.3%) experienced MACE [23 males, 9 females; age: (75.44±13.45) years]. In the STEAMI patients, IL-1β was elevated in patients with MACE compared with patients without MACE (median [range]: 26.52 [12.010 to 155.244] pg/mL vs 2.157 [0.433 to 83.021] pg/mL; P < 0.01) by non-parameter analysis. Significant and positive correlations be-tween IL-1β and cardiac troponin-I (cTnI) (r = 0.353, P =0.004) were observed by Spearman's correlations analysis. Multivariate logistic regression analysis revealed that IL-1β levels ≥20 pg/mL were significantly and in-dependently associated with MACE during hospitalization (odds ratio: 32.05; 95% confidence interval: 4.28 to 240.151; P =0.001). Conclusions The present study revealed that patients with STEAMI had elevated IL-1β levels on admission. The plasma IL- 1β level is an independent inflammatory predictor for in-hospital MACE in pa-tients with STEAMI undergoing percutaneous coronary intervention.

Study on the correlation between HMGB1-IL-23/IL-17A inflammatory axis and the prognosis of percutaneous coronary intervention

Impact Of Increased Inflammation Biomarkers On Periprocedural Myocardial Infarction In Patients Undergoing Elective Percutaneous Coronary Intervention: A Cohort Study

IL-6 and HMGB1 Levels for Predicting Major Adverse Vascular Events after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome

Correlation Between Prognosis of the CHD and Infection of Chlamydia Pneumonia and Inflammatiory Reaction

Relationships Between Level of Plasma Interleukin-33 and Prognosis in Patients with Acute Coronary Syndrome

Effect of the Plasma Interleukin- 1β Level on Prognosis of Patients with ST-segment Elevation Acute Myocardial Infarction

Associations of Myeloperoxidase, Interleukin-17A and Heparin-Binding EGF-like Growth Factor Levels with In-Stent Restenosis after Percutaneous Coronary Intervention: a Single-Centre Case–control Study in China

Changes of Serum Interleukin- 10 and Interleukin- 18 Before and After Coronary Intervention Therapy and Its Correlation with Cardiovascular Events

Detection of Inflammatory Factors in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention and their Relationships with Prognosis

The Effect of Percutaneous Coronary Intervention on the Activities of Peripheral Blood Monocytes and Inflammation in Patients with Stable Angina Pectoris

Potential roles of IL-38, among other inflammation-related biomarkers, in predicting post-percutaneous coronary intervention cardiovascular events

Correlation of severity of coronary lesions and prognosis of the CHD and infection of chlamydia pneumonia and inflammatory reaction

Increased Serum Il-17a Is Associated With Hmgb1 In Coronary Artery Disease

The relationship between levels of tumor necrosis factor-alpha, interleukin-6, and C-reactive protein in the serum of elderly and acute myocardial infarction

Relationship Between Interleukin-18 Levels and Characterization of Atherosclerotic Plaque and Percutaneous Coronary Intervention

Roles of ST2, IL-33 and BNP in predicting major adverse cardiovascular events in acute myocardial infarction after percutaneous coronary intervention.

Increased serum HMGB1 is related to the severity of coronary artery stenosis.

C-Reactive Protein and Inflammatory Cytokines During Percutaneous Coronary Intervention

Interleukin-18 Levels on Admission Are Associated with Mid-Term Adverse Clinical Events in Patients with ST-Segment Elevation Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

Relationship Between Plasma Level of IL-18,ox-LDL and the Development of Emergency Percutaneous Coronary Intervention

[Changes of Plasma High-Sensitive C-reactive Protein and Monocyte Chemotactic Factor-1 Following Percutaneous Coronary Interventional Procedures in Patients with Coronary Artery Disease].